Life Science Companies Grow in the UK Since the Launch of the Life Sciences Industrial Strategy
15 January 2020
Since the launch of the Life Sciences Industrial Strategy in August 2017, the UK is becoming a more attractive place for life sciences companies to grow and succeed.
This substantial progress is a result of the collaboration between pharma, biotech, medtech, digital and diagnostics, NHS and government.
The Life Sciences Industrial Strategy Update highlights what has been achieved so far:
Commitment to boost UK spending on R&D to 2.4% GDP by 2027
Commitment to increase NHS update of best value treatments and technologies with a funding package for the NHS that is now in place
Supported investment into knowledge intensive sectors like life sciences through a number of programmes and national infrastructures
The world’s largest genomics project has been launched
Digital Innovation Hub Programme has been launched
A centralised data-enabled clinical trials service has been designed and piloted
Implementing a new national approach to costing and contracting for commercial contract research
Ensured the UK has the best talent, skills and people to support the sector
Ridge are supporting various clients with research and development projects including, the University of Oxford and MEPC Milton Park contributing to the strategy.